Skip to main content

Table 2 Proportion of patients (%) and medians for health care use during 2012 by patient group

From: Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study

 

Schizophrenia (%)

NAP (%)

RR

95% CI

Inpatient carea

25.01

29.34

0.85

0.82–0.90

Outpatient carea

84.10

76.69

1.08

1.08–1.11

Primary care

63.29

66.49

0.95

0.78–1.17

Psychiatric carea

78.64

60.04

1.31

1.28–1.33

No Psychiatric carea

21.36

39.96

0.54

0.51–0.56

 

Schizophrenia (medians, range)

NAP (medians, range)

Wilcoxon rank sum test/χ2 statistics

P-value

Primary care consultations b

2 (0–1142)

2 (0–1023)

18.51

<0.0001

Outpatient consultations b

23 (0–1303)

14 (0–2335)

319.94

<0.0001

Outpatient psychiatric consultationsb

13 (0–1123)

3 (0–226)

879.01

<0.0001

Inpatient admissions b

0 (0–93)

0 (0–45)

46.75

<0.0001

Inpatient psychiatric admissionsb

0 (0–63)

0 (0–39)

13.72

0.0002

Inpatient care, daysb

0 (0–364)

13 (1–336)

25.77

<0.0001

Inpatient psychiatric care, daysb

0 (0–364)

0 (0–337)

5.82

0.02

  1. Note: The categories ‘Inpatient care’ and ‘Outpatient care’ include somatic and psychiatric consultations. ‘Psychiatric care’ includes inpatient and outpatient psychiatric care. Psychiatric care given at the primary level of care is not included
  2. aStatistically significant difference in RR between the two diagnostic groups (95% CI for RR)
  3. bStatistically significant difference between the two diagnostic groups by Wilcoxon rank sum test/χ2 statistics